Evidence map›Paper›PMID 7573372›Full record

ArticleThe American journal of pathology1995

Embryonic fibronectin isoforms are synthesized in crescents in experimental autoimmune glomerulonephritis.

V Nickeleit, L Zagachin, K Nishikawa, J H Peters, R O Hynes, R B Colvin

Abstract read
In one paragraph

Article in The American journal of pathology, 1995. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 30 citations in OpenAlex.

  1. Correlations between plasma levels of a fibronectin isoform subpopulation and C-reactive protein in patients with systemic inflammatory disease.Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals · 2009
    Article
  2. Article
  3. Article
  4. Article
  5. Tissue factor in crescentic glomerulonephritis.The American journal of pathology · 1997
    Review
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

V NickeleitDepartment of Pathology, Massachusetts General Hospital, Boston 02114, USA.
L Zagachin
K Nishikawa
J H Peters
R O Hynes
R B Colvin
Massachusetts General Hospital · US

Funding

STUDY OF THE FIBRONECTIN FUNCTIONP01HL041484 · NHLBI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI ROSENBERG, ROBERT D · 1988 to 2000
$2.7M
IMMUNOPATHOLOGY OF NEPHRITIS AND RENAL ALLOGRAFTSR01DK036807 · NIDDK · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI ANDRES, GIUSEPPE A · 1986 to 1998
–
CELL INTERACTION AND THE CLOTTING SYSTEMR37CA020822 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI COLVIN, ROBERT B · 1988 to 1995
–
NCI NIH HHS R37CA20822NHLBI NIH HHS P01HL41484NIDDK NIH HHS DK-36807
6 · The paper itself

Abstract

Crescents are a severe and stereotyped glomerular response to injury that occur in several forms of glomerulonephritis that progress to renal failure. The key pathogenetic step that leads to glomerular scarring in unknown, but fibronectin (FN), the clotting system, macrophages, and proliferating parietal epithelial cells are known to participate. This study was designed to determine whether FN is synthesized locally, and in what molecular isoform, and whether cytokines known to promote FN synthesis are present in the crescent. Rats immunized with bovine glomerular basement membrane develop cellular crescents by 14 days and fibrous crescents and glomerulosclerosis by 35 days. In situ hybridization was performed with oligonucleotides specific for sequences common to all FN isoforms (total FN) or sequences specific for the alternatively spliced segments (EIIIA, EIIIB, and V). Throughout the time period (14, 21, and 35 days) all crescents and glomerular tufts contained cells with strong ISH signals for total and V+ mRNA, with the strongest signals present in large cellular crescents at day 21. In contrast, EIIIA+ and EIIIB+ mRNAs showed maximal abundance within sclerosing crescents at 35 days. Protein deposition of EIIIA+, EIIIB+, and V+ FN isoforms was confirmed by immunofluorescence with segment-specific FN antibodies. Transforming growth factor-beta and interleukin-1 beta, both known to promote FN synthesis, were found in cellular crescents (days 14 and 21) and were still present, but greatly diminished, in the sclerotic phase (day 35). In summary, EIIIA-, EIIIB-, and V+ FN mRNA plasma isoforms predominate in cellular crescents, whereas in the fibrosing stage, mainly the oncofetal EIIIA+, EIIIB+, and V+ isoforms are synthesized and accumulate.

Indexed as

Alternative SplicingAnimalsAutoimmune DiseasesBase SequenceCattleEmbryo, MammalianFibronectinsFluorescent Antibody Technique, IndirectGlomerulonephritisImmunoenzyme TechniquesIn Situ HybridizationIsomerismKidney GlomerulusMolecular Sequence DataOligonucleotide ProbesRatsFibronectinsOligonucleotide ProbesRNA, Messenger

Identifiers

PMID7573372
PMCPMC1871008
OpenAlexW1473716571

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.